Omeprazole or ranitidine in long-term treatment of reflux esophagitis
- 1 November 1994
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 107 (5) , 1305-1311
- https://doi.org/10.1016/0016-5085(94)90531-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with RanitidineScandinavian Journal of Gastroenterology, 1991
- Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.Gut, 1990
- Omepmazole or high‐dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’of H2‐receptor antagonistsAlimentary Pharmacology & Therapeutics, 1990
- Reflux EsophagitisScandinavian Journal of Gastroenterology, 1990
- Epidemiology of Reflux Disease and Reflux EsophagitisScandinavian Journal of Gastroenterology, 1989
- Healing and relapse of severe peptic esophagitis after treatment with omeprazoleGastroenterology, 1988
- Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitisDigestive Diseases and Sciences, 1988
- Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trialBMJ, 1988
- Omeprazole or Ranitidine in the Treatment of Reflux Esophagitis: Results of a Double-Blind, Randomized, Scandinavian Multicenter StudyScandinavian Journal of Gastroenterology, 1987
- DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITISThe Lancet, 1987